Summit Therapeutics SMMT Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's deferred tax assets and other non-current assets?
- Summit Therapeutics (SMMT) reported deferred tax assets and other non-current assets of $8.23M in Q1 2026.
- How has Summit Therapeutics's deferred tax assets and other non-current assets changed year-over-year?
- Summit Therapeutics's deferred tax assets and other non-current assets increased by 98.6% year-over-year, from $4.15M to $8.23M.